News
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...
MedPage Today on MSN1d
Novel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisThe dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...
WEDNESDAY, April 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback